1-(4-Methyl-1H-imidazol-2-yl)ethanone

Catalog No. :
ACSPJD627
CAS No. :
2524-90-5
Molecular Formula :
C6H8N2O
Molecular Weight :
124.14

IUPAC Name:1-(4-methyl-1H-imidazol-2-yl)ethan-1-one

1-(4-Methyl-1H-imidazol-2-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$59.00Login to see priceIn stockInquiry
250mg95%$71.00Login to see priceIn stockInquiry
1g95%$281.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Methyl-1H-imidazol-2-yl)ethanone
IUPAC Name1-(4-methyl-1H-imidazol-2-yl)ethan-1-one
MDL No.MFCD08668179
Molecular FormulaC6H8N2O
Molecular Weight124.14
SMILESCC(C1=NC(C)=CN1)=O
InChI KeyXSLIWFPYEWEYLL-UHFFFAOYSA-N
Synonym1-(4-METHYL-1H-IMIDAZOL-2-YL)-ETHANONE;2-Acetyl-4-methyl-1H-imidazole;4-Methyl-1H-imidazol-2-yl(methyl) ketone;2-Acetyl-4-methylimidazole;1-(4-methyl-1H-imidazol-2-yl)ethanone(SALTDATA: FREE);Ethanone, 1-(4-methyl-1H-imidazol-2-yl)-;Ketone, methyl 4(or 5)-methylimidazol-2-yl;1-(4-methyl-3H-imidazol-2-yl)ethanone
CAS No.2524-90-5
PubChem CID565883

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSPJD627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSPJD627 route product structure diagram
    ACSPJD6272524-90-5 In Stock
Inquiry

2. ACSPJD627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSPJD627 route product structure diagram
    ACSPJD6272524-90-5 In Stock
Inquiry

Comments (0)